Sigyn Therapeutics Inc. (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. Jim Joyce, CEO of Sigyn Therapeutics, joins us to discuss the how his company's development of therapies looks to address conditions that are beyond the reach of drugs. Going into 2025, Sigyn Therapeutics is looking to create therapies to target cancer cells to prep patients beginning chemotherapy. Tune in to learn more!
View Podcast Transcript
Información
- Programa
- FrecuenciaDos veces al mes
- Publicado18 de septiembre de 2024, 12:00 UTC
- Duración11 min
- Temporada8
- Episodio26
- ClasificaciónApto